Samarth Kulkarni

Insider Reports History

Entity
Individual
Location
C/O Crispr Therapeutics Ag, 200 Sidney Street, Cambridge, MA
Signature
/s/ Paul Quinlan, as attorney-in-fact for Samarth Kulkarni
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samarth Kulkarni:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Chief Executive Officer, Director Common Shares 223K $12.5M $56.09 Aug 8, 2024 Direct
CRISPR Therapeutics AG Chief Executive Officer, Director Common Shares 85.6K $4.8M $56.09 Aug 8, 2024 The Kulkarni 2023 GRAT
CRISPR Therapeutics AG Chief Executive Officer, Director Restricted Stock Units 78.8K Mar 20, 2024 Direct
Centessa Pharmaceuticals plc Director Share Option (right to buy) 48K Jun 25, 2024 Direct
Black Diamond Therapeutics, Inc. Director Stock Option (Right to Buy) 30.6K Jun 6, 2024 Direct
Repare Therapeutics Inc. Director Stock Option (right to buy) 27.2K Jun 17, 2024 Direct
CRISPR Therapeutics AG Chief Executive Officer, Director Stock Option (Right to Buy) 0 Apr 15, 2024 Direct

Insider Reports Filed by Samarth Kulkarni

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ORKA Oruka Therapeutics, Inc. Aug 29, 2024 0 $0 3 Sep 6, 2024 Director
CRSP CRISPR Therapeutics AG Aug 8, 2024 1 $0 4 Aug 12, 2024 Chief Executive Officer, Director
CNTA Centessa Pharmaceuticals plc Jun 25, 2024 1 $0 4 Jun 27, 2024 Director
RPTX Repare Therapeutics Inc. Jun 17, 2024 1 $0 4 Jun 20, 2024 Director
BDTX Black Diamond Therapeutics, Inc. Jun 6, 2024 1 $0 4 Jun 6, 2024 Director
CRSP CRISPR Therapeutics AG Apr 15, 2024 4 -$799K 4 Apr 17, 2024 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Mar 20, 2024 2 $0 4 Mar 22, 2024 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Mar 15, 2024 4 -$1.07M 4 Mar 18, 2024 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Mar 10, 2024 6 -$1.11M 4 Mar 12, 2024 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Feb 18, 2024 3 -$507K 4 Feb 21, 2024 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Feb 15, 2024 5 -$1.22M 4 Feb 16, 2024 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Jan 29, 2024 4 -$2.07M 4 Jan 31, 2024 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Jan 16, 2024 3 -$868K 4 Jan 18, 2024 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Oct 13, 2023 2 $0 4 Oct 17, 2023 Chief Executive Officer, Director
CNTA Centessa Pharmaceuticals plc Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
RPTX Repare Therapeutics Inc. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
CRSP CRISPR Therapeutics AG May 30, 2023 6 -$1.14M 4 Jun 1, 2023 Chief Executive Officer, Director
BDTX Black Diamond Therapeutics, Inc. May 16, 2023 1 $0 4 May 17, 2023 Director
CRSP CRISPR Therapeutics AG Apr 25, 2023 4 -$789K 4 Apr 27, 2023 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Mar 29, 2023 4 -$634K 4 Mar 31, 2023 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Mar 10, 2023 8 -$408K 4 Mar 14, 2023 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Feb 27, 2023 5 -$728K 4 Mar 1, 2023 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Feb 18, 2023 3 -$308K 4 Feb 22, 2023 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Jan 27, 2023 4 -$809K 4 Jan 31, 2023 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Dec 28, 2022 4 -$545K 4 Dec 30, 2022 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Dec 6, 2022 2 $105K 4 Dec 8, 2022 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Dec 3, 2022 3 -$1.01M 4 Dec 6, 2022 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Nov 28, 2022 5 -$873K 4 Nov 30, 2022 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Oct 26, 2022 8 -$949K 4 Oct 28, 2022 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Sep 28, 2022 4 -$1.21M 4 Sep 30, 2022 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Aug 29, 2022 5 -$1.27M 4 Aug 31, 2022 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Aug 16, 2022 2 $0 4 Aug 18, 2022 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Jul 27, 2022 10 -$1.52M 4 Jul 29, 2022 Chief Executive Officer, Director
CNTA Centessa Pharmaceuticals plc Jun 30, 2022 1 $0 4 Jul 5, 2022 Director
CRSP CRISPR Therapeutics AG Jun 29, 2022 4 -$1.23M 4 Jul 1, 2022 Chief Executive Officer, Director
BDTX Black Diamond Therapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 13, 2022 Director
RPTX Repare Therapeutics Inc. May 13, 2022 1 $0 4 May 16, 2022 Director
CRSP CRISPR Therapeutics AG Mar 10, 2022 6 -$597K 4 Mar 14, 2022 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Feb 18, 2022 2 $0 4 Feb 22, 2022 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Dec 20, 2021 2 $32.1K 4 Dec 22, 2021 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Dec 3, 2021 3 -$2.62M 4 Dec 7, 2021 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Dec 1, 2021 1 -$58.5K 4 Dec 3, 2021 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Oct 15, 2021 3 $59.7K 4 Oct 18, 2021 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Sep 1, 2021 1 -$98.2K 4 Sep 3, 2021 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Aug 4, 2021 10 -$3.49M 4 Aug 6, 2021 Chief Executive Officer, Director
BDTX Black Diamond Therapeutics, Inc. Jun 18, 2021 1 $0 4 Jun 22, 2021 Director
CRSP CRISPR Therapeutics AG Jun 15, 2021 5 -$3.42M 4 Jun 17, 2021 Chief Executive Officer, Director
CRSP CRISPR Therapeutics AG Jun 1, 2021 1 -$90.2K 4 Jun 3, 2021 Chief Executive Officer, Director
CNTA Centessa Pharmaceuticals plc May 27, 2021 0 $0 3 May 27, 2021 Director
RPTX Repare Therapeutics Inc. May 13, 2021 1 $0 4 May 14, 2021 Director